But even today, more than three decades after BPC-157 was first synthesized, a grand total of three human studies have been conducted, and none of them were the kind of large-scale human trial thats typically part of the traditional drug-approval process
The benefits and drawbacks of oral glutathione depend on formulation type and dosing
GHK-Cu starts low and steps up mid-cycle
Chen X, Wei W, Li Y, Huang J, Ci X (2019) Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis
Post-Treatment : After the IV is removed, you can immediately resume normal activities with no downtime required
It does not allow for ad hoc distribution of new, unapproved medicines